ADAMTS9 and urinary bladder cancer: ADAMTS9-AS1 can inhibit apoptosis and autophagy through the PI3K/AKT/mTOR signaling pathway and promote bladder cancer progression (Yang et al., 2021) while inhibiting colon cancer cell progression through the Wnt/β-catenin signaling pathway (Li et al., 2020).